SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-050861
Filing Date
2020-11-05
Accepted
2020-11-05 07:15:38
Documents
62
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sage-10q_20200930.htm   iXBRL 10-Q 3255910
2 EX-31.1 sage-ex311_10.htm EX-31.1 9354
3 EX-31.2 sage-ex312_9.htm EX-31.2 9288
4 EX-32.1 sage-ex321_6.htm EX-32.1 8657
5 GRAPHIC gidzru35fw2v000001.jpg GRAPHIC 33949
  Complete submission text file 0001564590-20-050861.txt   9758326

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA sage-20200930.xsd EX-101.SCH 52290
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20200930_cal.xml EX-101.CAL 43028
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20200930_def.xml EX-101.DEF 199495
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20200930_lab.xml EX-101.LAB 405690
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20200930_pre.xml EX-101.PRE 322777
11 EXTRACTED XBRL INSTANCE DOCUMENT sage-10q_20200930_htm.xml XML 1840150
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 201288657
SIC: 2834 Pharmaceutical Preparations